Vergleich

PHT-427 Europäischer Partner

ArtNr S1556-10
Hersteller Selleckchem
CAS-Nr. 1191951-57-1
Menge 10 mg
Quantity options 10 mg 1 g 10 g 10 mM/1 ml 200 mg 50 mg 5 g
Kategorie
Typ Inhibitors
Specific against other
Smiles CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)NC2=NN=CS2
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias CS-0223
Similar products PHT-427
Lieferbar
Manufacturer - Targets
PDPK1
Storage Conditions
2 years -80 in solvent
Molecular Weight
409, 61
Administration
Oral administration
Animal Models
BxPC-3, Panc-1, MiaPaCa-2, PC-3, SKOV-3, A-549 or MCF-7 cells are injected subcutaneously into the flanks of female scid mice.
Cell lines
Panc-1 cells
Concentrations
1-50 uM
Dosages
125-250 mg/kg
Formulation
40 to 50 mg/mL in sesame seed oil
IC50
2.7 uM, 2.7 uM, 2.7 uM, 2.7 uM, 2.7 uM, 2.7 uM
In vitro
PH-427 is a pleckstrin homology domain inhibitor to Akt/PDPK1. PH-427 significantly reduces phospho-Ser241-PDPK1 phospho-Thr308-Akt in PC-3 prostate cancer cells at 10 uM, which shows that PHT-427 could inhibit both Akt and PDKP1. PHT-427 also inhibits translocation of the Akt and PDKP1 PH domains in plasma membrane. [1] PHT-427 induces apoptosis and inhibits AKT phosphorylation with IC50 of 8.6 uM (in BxPC-3 cells), which mainly on its Ser473 residue and less strongly on Thr308 residue without affecting total Akt protein expression. PHT-427 also shows antiproliferation in Panc-1 cells with IC50 of 65 uM. [2]
In vivo
PHT-427 shows great antitumor activity in BxPC-3 pancreatic, MCF-7 breast and A-549 NSCL cancer xenografts. PHT-427 gives up to an 80% inhibition of tumor growth in BxPC-3 at doses of 125 to 250 mg/kg. [1]
Kinase Assay
Surface plasmon resonance (SPR) spectroscopy binding assays, All interaction analyses are performed with a Biacore 2000, Biacore 2000 Control Software v3.2, and BIAevaluation v4.1 analysis software. The PH domain GST-fusion proteins (Akt1, IRS1, and PDK1) are immobilized on a CM5 Sensorchip using Biacore's Amine Coupling Kit to a level of 10, 000 Response units (RUs). Small molecule analytes at concentrations ranging from 0.1 to 10, the predicted KD are injected at a high flow rate (30uL/min). DMSO concentrations in all samples and running buffer are 1% (v/v) or less.
Method
Cell growth inhibition is determined using a micro-cytoxicity assay. Cells are plated in 96-well micro-cytoxicity at 5-10, 103 cells per well (depending on cell doubling time) and grown for 7 days. PHT-427 dissolved in DMSO is added directly to the media, at various concentrations ranging from 1 to 50 uM. The endpoint is spectrophotometric determination of the protein content of each well using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide. A concentration-response relationship at two or more concentration levels is used to obtain an IC50 for PHT-427.
Solubility (25C)
DMSO 82 mg/mL, Water <1 mg/mL, Ethanol 60 mg/mL
Information
PHT-427 (CS-0223) is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.7 μM and 5.2 μM, respectively.
Chemical Name
4-dodecyl-N-(1, 3, 4-thiadiazol-2-yl)benzenesulfonamide

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?